Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JIL
|
|||
| Former ID |
DNC006665
|
|||
| Drug Name |
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide
|
|||
| Synonyms |
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide; 301675-24-1; CHEMBL210658; N-(1H-benzimidazol-2-yl)-3-nitrobenzamide; AC1MTB3N; Cambridge id 7283005; Oprea1_384876; Oprea1_144350; MLS000418401; SCHEMBL3597174; MolPort-007-653-805; QPKROMNIEAEFQA-UHFFFAOYSA-N; MolPort-001-543-036; ZINC5033955; CS-M1436; STK433528; BDBM50184701; AKOS001825502; AKOS001141441; MCULE-1403873826; KB-78995; SMR000264931; CS-13909; ST50927847; N-benzimidazol-2-yl(3-nitrophenyl)carboxamide; 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10N4O3
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)NC(=N2)NC(=O)C3=CC(=CC=C3)[N+](=O)[O-]
|
|||
| InChI |
1S/C14H10N4O3/c19-13(9-4-3-5-10(8-9)18(20)21)17-14-15-11-6-1-2-7-12(11)16-14/h1-8H,(H2,15,16,17,19)
|
|||
| InChIKey |
QPKROMNIEAEFQA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.